TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

How anticoagulants may impact a patient’s risk of gastrointestinal bleeding after TAVR
Researchers tracked the rates of major gastrointestinal bleeding in patients with AFib randomized to receive edoxaban or a vitamin K antagonist after a successful TAVR procedure.
Boston Scientific pulls plug on TAVR devices after failing to gain FDA approval
After years of trying to catch up with the competition, Boston Scientific is moving on. The company is no longer seeking approval from the FDA or any other regulatory agencies for these devices, and all global sales have been discontinued.
Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards
Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial.
Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs
Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.
Medtronic gains a key approval for Evolut TAVR valves
More patients can now undergo redo TAVR with a Medtronic valve than ever before.

FDA clears new device for valve-in-valve TAVR patients at risk of coronary obstruction

ShortCut, which gained the FDA’s breakthrough device designation back in January, is used to split valve leaflets and reduce the risk of obstruction.

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

Reduced LVEF before TAVR linked to lower long-term survival rate

Heart teams already view reduced LVEF as a potential risk factor, but research into its long-term impact on patient outcomes has been limited.

Long-term survival after valve-in-valve TAVR similar with self-expanding, balloon-expandable valves

Severe prosthesis-patient mismatch was more common with balloon-expandable valves, but that difference did not appear to impact outcomes.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

LBBAP limits hospital readmissions after TAVR

Left bundle branch area pacing is associated with better long-term outcomes than traditional right ventricular pacing when patients require PPMI after TAVR, according to new research in Heart Rhythm.

SAVR associated with several long-term benefits for patients with asymptomatic severe AS

The current evidence suggests early surgery is a better treatment option for asymptomatic severe AS than conservative care, researchers explained.

Balloon-expandable transcatheter aortic valve replacement (TAVR) valves that fail to expand symmetrically may be associated with worse hemodynamic data, according to a new analysis published in JACC: Cardiovascular Interventions.

Asymmetrical valve expansion after TAVR a cause for concern

Calcified debris can sometimes lead to stent frame issues that cause a patient's TAVR valve to expand asymmetrically. Few studies have explored the potential impact of valve asymmetry—until now.

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

FDA clears AI platform for planning ahead of TAVR, other heart procedures

The cloud-based platform identifies and measures cardiac structures in CT scans.

‘An excellent outcome’: TAVR safe and effective for patients in their nineties

Bleeding and vascular complications were more common, but one-year outcomes confirmed patients in their nineties should still be considered for TAVR.

TAVR

How anticoagulants may impact a patient’s risk of gastrointestinal bleeding after TAVR

Boston Scientific pulls plug on TAVR devices after failing to gain FDA approval

Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Medtronic gains a key approval for Evolut TAVR valves